Pongvongsa, Tiengkham
Phommasone, Koukeo
Adhikari, Bipin https://orcid.org/0000-0001-8981-3910
Henriques, Gisela
Chotivanich, Kesinee
Hanboonkunupakarn, Borimas
Mukaka, Mavuto
Peerawaranun, Pimnara
von Seidlein, Lorenz
Day, Nicholas P. J.
White, Nicholas J.
Dondorp, Arjen M.
Imwong, Mallika
Newton, Paul N.
Singhasivanon, Pratap
Mayxay, Mayfong
Pukrittayakamee, Sasithon
Clinical trials referenced in this document:
Documents that mention this clinical trial
Intracluster correlation coefficients in the Greater Mekong Subregion for sample size calculations of cluster randomized malaria trials
https://doi.org/10.1186/s12936-019-3062-x
Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia
https://doi.org/10.1186/s12936-018-2390-6
The dynamic of asymptomatic Plasmodium falciparum infections following mass drug administrations with dihydroarteminisin–piperaquine plus a single low dose of primaquine in Savannakhet Province, Laos
https://doi.org/10.1186/s12936-018-2541-9
Submicroscopic Plasmodium prevalence in relation to malaria incidence in 20 villages in western Cambodia
https://doi.org/10.1186/s12936-017-1703-5
The probability of a sequential Plasmodium vivax infection following asymptomatic Plasmodium falciparum and P. vivax infections in Myanmar, Vietnam, Cambodia, and Laos
https://doi.org/10.1186/s12936-019-3087-1
Funding for this research was provided by:
Bill and Melinda Gates Foundation
Wellcome Trust
Article History
Received: 27 August 2018
Accepted: 20 October 2018
First Online: 3 November 2018